Navigation Links
UPDATE: FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
Date:3/1/2011

SILVER SPRING, Md., March 1, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups (exacerbations) or worsening of symptoms from severe chronic obstructive pulmonary disease (COPD).

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)  

COPD is a serious lung disease that makes breathing difficult. Symptoms can include breathlessness, chronic cough, and excessive phlegm. An exacerbation can last up to several weeks and result in lung function decline, increased risk of death, and may be associated with severe anxiety.

Cigarette smoking is the leading cause of COPD, according to the National Heart, Lung, and Blood Institute. COPD is the fourth leading cause of death in the United States.

Roflumilast, a new drug class for the treatment of COPD, is an inhibitor of an enzyme called phosphodiesterase type 4 (PDE-4). It is indicated for people with severe COPD to treat the symptoms of cough and excess mucus linked to bronchitis. Roflumilast is not intended to treat another form of COPD which involves primary emphysema.

"COPD is a serious disease that gets worse over time," said Curtis Rosebraugh, M.D., M.P.H., director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research. "New treatment options that reduce frequency of flare-ups or exacerbations are important in helping patients with COPD associated with chronic bronchitis and a history of exacerbations in managing this debilitating disease."

The safety and effectiveness of roflumilast was demonstrated in two Phase 3 clinical studies that included more than 1,500 patients ages 40 and older who received roflumilast. Those treated had a history of COPD associated with chronic bronchitis and had experienced an exacerbation of the disease during the 12 months prior to be
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. UPDATE: Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure
2. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
3. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
5. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
6. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
7. UPDATE: FDA Issues 22 Warning Letters to Web site Operators
8. Update: International HIV/AIDS Partnership Wins Two Awards for Supply Chain Excellence
9. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
10. Update: Clinical Trial Establishes Catheter-based Aortic Valve Replacement As New Standard of Care for Patients Who Cannot Undergo Surgery
11. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... WASHINGTON , July 24, 2014  The ... Brightree is supporting its mission to help address ... new and exclusive agreement to be the information ... service. As the leading provider of billing and ... brings unmatched HME industry expertise to support this ...
(Date:7/24/2014)... , July 24, 2014 Consolidated Net ... Business Highlights   , India Business grew ... by 9.33% to Rs. 4,886.70 Mn Rest of World ... Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn ... , Glenmark Pharmaceuticals Limited, the research-led global ...
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- "North America Orthopedic Braces ... data on the North America Orthopedic Braces and Supports ... dollars, and volume (in units) and average price data ... Knee Braces and Supports , Ankle Braces and ... Upper Extremities Braces and Supports. ...
Breaking Medicine Technology:Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5
... 8, 2011 The U.S. Food and Drug Administration today launched ... the safe disposal of needles and other so-called "sharps" that ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The website will ... disposing of used sharps and how users should safely dispose ...
... Nov. 8, 2011 Dengue v2V, a group of international ... in Puerto Rico on 5–6 November 2011 to continue to ... licensed. Dengue is a threat to almost half of the ... and Asia where epidemics are common.(1) "Puerto ...
Cached Medicine Technology:FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 2FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 3FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 4International Experts Outline Public Health Initiatives for Future Dengue Vaccine Introduction and Control of Dengue Fever 2International Experts Outline Public Health Initiatives for Future Dengue Vaccine Introduction and Control of Dengue Fever 3
(Date:7/24/2014)... may have found a way to delay or even ... neurons with the anti-aging protein Klotho can prevent neuron ... and glutamate. These findings currently appear in the ... is the most frequent age-related dementia affecting 5.4 million ... older and more than 40 percent of people over ...
(Date:7/24/2014)... 24, 2014 This year the Walk ... Electric and Jackson National Life, will be held on Saturday, ... am, the Kids Fun Run at 7:50 am, the untimed ... 9 a.m. , “The Walk to End Alzheimer’s unites the ... in the fight against this devastating disease, “stated Linda Mitchell, ...
(Date:7/24/2014)... 24, 2014 (HealthDay News) -- Drinking caffeine may worsen ... two-thirds of women as they go through menopause, new ... our study suggests that limiting caffeine intake may be ... flashes and night sweats," said researcher Dr. Stephanie Faubion, ... Clinic in Rochester, Minn. But caffeine -- a ...
(Date:7/24/2014)... or more equally positive outcomes experience paradoxical feelings ... in different regions of the brain, according to ... scholar at the Princeton Neuroscience Institute at Princeton ... rated the desirability of more than 300 products ... images of paired products with different or similar ...
(Date:7/24/2014)... Le Bonheur Children,s Hospital and the University of Tennessee ... of a new drug shown to safely reduce the ... intranasally infected with respiratory syncytial virus (RSV). RSV is ... in young children in the United States and worldwide. ... Infectious Disease Specialist John DeVincenzo, MD. DeVincenzo,s Le Bonheur ...
Breaking Medicine News(10 mins):Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 3Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:Brain's dynamic duel underlies win-win choices 2Health News:Brain's dynamic duel underlies win-win choices 3Health News:RSV research breakthrough to help infected children 2
... with lung cancer remains to be established, a new ... Journal of Thoracic Oncology provides compelling evidence of ... Researchers at China Medical University and Hospital in Taiwan ... National Health Insurance (NHI) program. All patients aged 20 ...
... PROVIDENCE, R.I. [Brown University] A new study of ... seeking a hospice benefit and using it longer. The ... residents die with some degree of dementia. Researchers hope ... benefit even as they seek to control Medicare costs. ...
... By Dennis Thompson HealthDay Reporter , THURSDAY, ... played a big role in averting a major health crisis. ... pitch last winter, with public health officials fearing a widespread ... an epidemic was averted, and some health experts believe that,s ...
... , WEDNESDAY, Dec. 29 (HealthDay News) -- A treatment ... of patients suffering from multiple chronic illnesses such as ... in the Dec. 30 issue of the New ... four areas of blood sugar, blood pressure, cholesterol control ...
... Reporter , WEDNESDAY, Dec. 29 (HealthDay News) -- Consider this: ... cancer in the United States, killing about 157,300 people every ... according to the U.S. National Institutes of Health. , It ... only to heart disease. And yet lung cancer ...
... , WEDNESDAY, Dec. 29 (HealthDay News) -- People generally ... those of others, according to a new study. ... to 11 people. Each person talked with every other ... rated the other person,s physical attractiveness and five major ...
Cached Medicine News:Health News:Study finds evidence of increased lung cancer risk among tuberculosis patients 2Health News:Hospice care increasing for nursing home patients with dementia 2Health News:Hospice care increasing for nursing home patients with dementia 3Health News:Hand-Washing May Have Kept Flu at Bay 2Health News:Hand-Washing May Have Kept Flu at Bay 3Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 2Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 3Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 2Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 3Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 4
... Ethisorb Dura Patch is a synthetic absorbable ... and. spinalis defects. Ethisorb Dura Patch is pliable, ... cut to the desired shape, care must be ... violet dyed, PDS foil covered side is oriented ...
... More than a patch, Duragen is ... dura mater. Duragen handles and conforms ... an innovative collagen matrix for dural ... repair of dural defects. Fully resorbed ...
Elmed electrosurgical systems for major surgery....
Aaron 1250 is a multipurpose electrosurgical generator with monopolar and bi-polar functions....
Medicine Products: